期刊
CIRCULATION
卷 115, 期 25, 页码 3197-3204出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.106.657981
关键词
apoptosis; antioxidants; heart failure; hormones
资金
- NHLBI NIH HHS [R01 HL070274, R01 HL052233, R01 HL070274-02, R01 HL080187-01A1, R01 HL052233-12, R01 HL080187-03, R01 HL080187, HL080187, HL052233, R01 HL070274-04, R01 HL080187-02, R01 HL070274-01, R01 HL070274-05, R01 HL052233-11, R01 HL070274-03, R01 HL052233-10] Funding Source: Medline
- NIDDK NIH HHS [R01 DK062729, R01 DK062729-02, R01 DK062729-03, R01 DK062729-01A1, R01 DK062729-04, R01 DK062729-05] Funding Source: Medline
- NINDS NIH HHS [P01 NS010828-330036, P01 NS010828] Funding Source: Medline
Background - Epidemiological studies have shown gender differences in the incidence of congestive heart failure (CHF); however, the role of estrogen in CHF is not known. We hypothesize that estrogen prevents cardiomyocyte apoptosis and the development of CHF. Methods and Results - 17 beta-Estradiol (E2, 0.5 mg/60-day release) or placebo pellet was implanted subcutaneously into male G alpha q transgenic (Gq) mice. After 8 weeks, E2 treatment decreased the extent of cardiac hypertrophy and dilation and improved contractility in Gq mice. E2 treatment also attenuated nicotinamide adenine dinucleotide phosphate oxidase activity and superoxide anion production via downregulation of Rac1. This correlated with reduced apoptosis in cardiomyocytes of Gq mice. The antioxidative properties of E2 were also associated with increased expression of thioredoxin (Trx), Trx reductases, and Trx reductase activity in the hearts of Gq mice. Furthermore, the activation of apoptosis signal-regulating kinase 1 and its downstream effectors, c-Jun N-terminal kinase and p38 mitogen-activated protein kinase, in the hearts of Gq mice was reduced by long-term E2 treatment. Indeed, E2 (10 nmol/L)-treated cardiomyocytes were much more resistant to angiotensin II-induced apoptosis. These antiapoptotic and cardioprotective effects of E2 were blocked by an estrogen receptor antagonist (ICI 182,780) and by a Trx reductase inhibitor (azelaic acid). Conclusions - These findings indicate that long-term E2 treatment improves CHF by antioxidative mechanisms that involve the upregulation of Trx and inhibition of Rac1-mediated attenuated nicotinamide adenine dinucleotide phosphate oxidase activity and apoptosis signal-regulating kinase 1/c-Jun N-terminal kinase/p38 mitogen-activated protein kinase -mediated apoptosis. These results suggest that estrogen may be a useful adjunctive therapy for patients with CHF.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据